+Search query
-Structure paper
Title | Discovery of Clinical Candidate (1R,4r)-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol (Navoximod), a Potent and Selective Inhibitor of Indoleamine 2,3-Dioxygenase 1. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 62, Page 6705-6733, Year 2019 |
Publish date | Feb 26, 2019 (structure data deposition date) |
Authors | Kumar, S. / Waldo, J.P. / Jaipuri, F.A. / Marcinowicz, A. / Van Allen, C. / Adams, J. / Kesharwani, T. / Zhang, X. / Metz, R. / Oh, A.J. ...Kumar, S. / Waldo, J.P. / Jaipuri, F.A. / Marcinowicz, A. / Van Allen, C. / Adams, J. / Kesharwani, T. / Zhang, X. / Metz, R. / Oh, A.J. / Harris, S.F. / Mautino, M.R. |
External links | J. Med. Chem. / PubMed:31264862 |
Methods | X-ray diffraction |
Resolution | 2.69 Å |
Structure data | PDB-6o3i: |
Chemicals | ChemComp-HEM: ChemComp-LKP: ChemComp-HOH: |
Source |
|
Keywords | OXIDOREDUCTASE/INHIBITOR / Dioxygenase / tryptophan / IDO / TDO / OXIDOREDUCTASE-INHIBITOR complex |